Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2 beta

被引:233
作者
Moser, M
Pscherer, A
Roth, C
Becker, J
Mucher, G
Zerres, K
Dixkens, C
Weis, J
GuayWoodford, L
Buettner, R
Fassler, R
机构
[1] UNIV REGENSBURG,SCH MED,INST PATHOL,D-93042 REGENSBURG,GERMANY
[2] UNIV BONN,INST HUMAN GENET,D-53111 BONN,GERMANY
[3] UNIV ULM,DEPT MED GENET,D-89069 ULM,GERMANY
[4] RHEIN WESTFAL TH AACHEN,INST NEUROPATHOL,D-52057 AACHEN,GERMANY
[5] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
[6] UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294
[7] MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,GERMANY
关键词
AP-2; beta; gene targeting; apoptosis; c-myc; ARPKD;
D O I
10.1101/gad.11.15.1938
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Expression of AP-2 transcription factors has been detected previously in embryonic renal tissues. We show here that AP-2 beta -/- mice complete embryonic development and die at postnatal days 1 and 2 because of polycystic kidney disease. Analyses of kidney development revealed that induction of epithelial conversion, mesenchyme condensation, and further glomerular and tubular differentiation occur normally in AP-2 beta-deficient mice. At the end of embryonic development expression of bcl-X-L, bcl-w, and bcl-2 is down-regulated in parallel to massive apoptotic death of collecting duct and distal tubular epithelia. Addressing the molecular mechanism we show that transfection of AP-2 into cell lines in vitro strongly suppresses c-myc-induced apoptosis pointing to a function of AP-2 in programming cell survival during embryogenesis. The position of the human AP-2 beta gene was identified at chromosome 6p12-p21.1, within a region that has been mapped for autosomal recessive polycystic kidney disease (ARPKD). Sequence analyses of ARPKD patients and linkage analyses using intragenic polymorphic markers indicate that the AP-2 beta gene is located in close proximity to but distinct from the ARPKD gene.
引用
收藏
页码:1938 / 1948
页数:11
相关论文
共 29 条
[1]   THE GENOMIC STRUCTURE OF THE HUMAN AP-2 TRANSCRIPTION FACTOR [J].
BAUER, R ;
IMHOF, A ;
PSCHERER, A ;
KOPP, H ;
MOSER, M ;
SEEGERS, S ;
KERSCHER, M ;
TAINSKY, MA ;
HOFSTAEDTER, F ;
BUETTNER, R .
NUCLEIC ACIDS RESEARCH, 1994, 22 (08) :1413-1420
[2]   APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2 [J].
BISSONNETTE, RP ;
ECHEVERRI, F ;
MAHBOUBI, A ;
GREEN, DR .
NATURE, 1992, 359 (6395) :552-554
[3]   THE DEVELOPMENTALLY-REGULATED TRANSCRIPTION FACTOR AP-2 IS INVOLVED IN C-ERBB-2 OVEREXPRESSION IN HUMAN MAMMARY-CARCINOMA [J].
BOSHER, JM ;
WILLIAMS, T ;
HURST, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :744-747
[4]   AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis [J].
Chazaud, C ;
OuladAbdelghani, M ;
Bouillet, P ;
Decimo, D ;
Chambon, P ;
Dolle, P .
MECHANISMS OF DEVELOPMENT, 1996, 54 (01) :83-94
[5]  
COLES HSR, 1993, DEVELOPMENT, V118, P777
[6]   TRANSCRIPTIONAL ACTIVATION BY MYC IS UNDER NEGATIVE CONTROL BY THE TRANSCRIPTION FACTOR AP-2 [J].
GAUBATZ, S ;
IMHOF, A ;
DOSCH, R ;
WERNER, O ;
MITCHELL, P ;
BUETTNER, R ;
EILERS, M .
EMBO JOURNAL, 1995, 14 (07) :1508-1519
[7]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[8]  
GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033
[9]   N-RAS ONCOGENE CAUSES AP-2 TRANSCRIPTIONAL SELF-INTERFERENCE, WHICH LEADS TO TRANSFORMATION [J].
KANNAN, F ;
BUETTNER, R ;
CHIAO, PJ ;
YIM, SO ;
SARKISS, M ;
TAINSKY, MA .
GENES & DEVELOPMENT, 1994, 8 (11) :1258-1269
[10]   An integrated genetic and physical map of the autosomal recessive polycystic kidney disease region [J].
Lens, XM ;
Onuchic, LF ;
Wu, GQ ;
Hayashi, T ;
Daoust, M ;
Mochizuki, T ;
Santarina, LB ;
Stockwin, JM ;
Mucher, G ;
Becker, J ;
Sweeny, WE ;
Avner, ED ;
GuayWoodford, L ;
Zerres, K ;
Somlo, S ;
Germino, GG .
GENOMICS, 1997, 41 (03) :463-466